Table 2.
Standardised incidence ratios of NHS–IC reported skin cancers in England compared with England population 2003–8 (including patients with previous skin cancer)
| Skin cancer (excluding melanoma) ICD-10 C44 | |||
|---|---|---|---|
| No | Expected | SIR (95% CI) | |
| nbDMARD | 39 | 21.34 | 1.83 (1.30 to 2.50) |
| Men | 15 | 8.97 | 1.67 (0.94 to 2.76) |
| Women | 24 | 12.38 | 1.94 (1.24 to 2.89) |
| Anti-TNF | 126 | 73.44 | 1.72 (1.43 to 2.04) |
| Men | 48 | 23.79 | 2.02 (1.49 to 2.68) |
| Women | 78 | 49.65 | 1.57 (1.24 to 1.96) |
ICD-10, International Classification of Diseases, 10th edition; nbDMARD, non-biological disease-modifying antirheumatic drug; NHS–IC, National Health Service Information Centre; SIR, standardised incidence ratio; TNF, tumour necrosis factor.